EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Amgen And Zai Lab DLL3 Alliance Adds New Dimension To Oncology Story
Assetmark Inc. Buys 14,341 Shares of Amgen Inc. $AMGN
Amgen (NASDAQ:AMGN) Upgraded at Wall Street Zen
Other news to note for April 14, 2026 | BioWorld
Smith Moore & CO. Sells 1,706 Shares of Amgen Inc. $AMGN - Daily Political
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial
Amgen (NASDAQ:AMGN) Price Target Raised to $400.00
Morgan Stanley Raises Amgen (AMGN) Target Ahead of Q1, Truist Lifts Outlook on Pipeline Strength
Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After New Lung Cancer Trial Progress And Amgen Collaboration
Amgen (NASDAQ:AMGN) Raised to "Buy" at Wall Street Zen - Stock Observer
Curtis Advisory Group LLC Makes New Investment in Amgen Inc. $AMGN
KG&L Capital Management LLC Lowers Stock Position in Amgen Inc. $AMGN - Stock Observer
Assessing Amgen (AMGN) Valuation As TEPEZZA And MariTide Trial Results Draw Fresh Investor Focus
Is It Time To Revisit Amgen (AMGN) After The Recent 4.6% Share Price Pullback
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry
Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB)
Amgen (NASDAQ:AMGN) Price Target Raised to $326.00
Amgen's Tarlatamab Receives Approval for Lung Cancer Treatment in China, ETPharma
Prime Capital Investment Advisors LLC Has $6.32 Million Stake in Amgen Inc. $AMGN - Markets Daily
Amgen's lung cancer drug tarlatamab wins China approval
8,657 Shares in Amgen Inc. $AMGN Purchased by Flagship Capital Management Inc.
Is Amgen (AMGN) One of the Most Profitable Value Stocks to Buy Right Now?
Overcoming MEN1-mediated resistance with menin inhibitor switching in KMT2A-rearranged acute myeloid leukemia
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT
What Amgen (AMGN)'s TEPEZZA On‑Body Injector Phase 3 Results Mean For Shareholders - Simply Wall St News
Amgen (NASDAQ:AMGN) Receives "Neutral" Rating from Cantor Fitzgerald - Markets Daily
Amgen (AMGN) Stock Surges on MariTide Weight Loss Data and Analyst Upgrades
Amgen (NASDAQ:AMGN) Price Target Raised to $351.00 - Stock Observer
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Healthequity (HQY) | Markets Insider
Amgen's Tepezza On Body Injector Data Tests Thyroid Eye Disease Moat
Investment Analysts' Updated EPS Estimates for April 8th (AIRO, AKTX, AMGN, ANIX, ASML, AVGO, BKNG, BMEA, BMY, BUD) - Stock Observer
Amgen (NASDAQ:AMGN) Earns Neutral Rating from Cantor Fitzgerald
Cantor Fitzgerald Reiterates Neutral Rating for Amgen (NASDAQ:AMGN) - Stock Observer
BIP Wealth LLC Acquires 8,785 Shares of Amgen Inc. $AMGN
Amgen's TEPEZZA Injector Data Sparks Questions On Value And Competition
Yousif Capital Management LLC Sells 2,504 Shares of Amgen Inc. $AMGN - Daily Political
Amgen Inc. (NASDAQ:AMGN) Receives $354.60 Average Price Target from Brokerages - Daily Political
ONTARIO AND QUEBEC EXPAND PUBLIC COVERAGE OF REPATHA® FOR ELIGIBLE RECENT ACUTE CORONARY SYNDROME PATIENTS
Amgen Inc. $AMGN Shares Sold by KFG Wealth Management LLC
Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - Daily Political
Robinhood Asset Management LLC Invests $17.53 Million in Amgen Inc. $AMGN - Daily Political
Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF) and Amgen (AMGN) | Markets Insider
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial
Medical Stocks To Watch Today - April 6th - Markets Daily
Viridian Shares Fall After Competing Amgen Eye Drug Performs Well | Morningstar
Amgen Posts Strong Phase 3 Trial Data for Subcutaneous Tepezza | Morningstar
BXM Wealth LLC Increases Stock Position in Amgen Inc. $AMGN
Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won't Pay a Dime | Investing.com
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
A Look At Zai Lab (ZLAB) Valuation After New Amgen Oncology Collaboration News
Analysts' Top Healthcare Picks: Amgen (AMGN), Airsculpt Technologies (AIRS) | Markets Insider
Amgen Inc. $AMGN Position Boosted by JB Capital LLC
A Look At Amgen (AMGN) Valuation After New Repatha Data And Zai Lab Oncology Collaboration
Amgen Inc. (NASDAQ:AMGN) Receives $354.60 Consensus PT from Brokerages - Markets Daily
Thurston Springer Miller Herd & Titak Inc. Purchases 3,354 Shares of Amgen Inc. $AMGN - Stock Observer
Sheets Smith Wealth Management Sells 1,626 Shares of Amgen Inc. $AMGN - Stock Observer
Aberdeen Group plc Acquires 27,107 Shares of Amgen Inc. $AMGN
How Tavneos Safety Risks and New Oncology Pact Could Rebalance Amgen's (AMGN) Risk‑Reward Profile
Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer
Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now?
HF Advisory Group LLC Buys 7,548 Shares of Amgen Inc. $AMGN
Amgen synthesizes new GTPase KRAS (G12D mutant) inhibitors | BioWorld
Other news to note for April 2, 2026 | BioWorld
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial
Spatially resolved osteoblast-traced transcriptomics uncovers TGF-β as a combination target with sclerostin in osteoporosis
Nisa Investment Advisors LLC Has $55.22 Million Stake in Amgen Inc. $AMGN
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co.
BTC Capital Management Inc. Sells 4,196 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Acquired by Moody Lynn & Lieberson LLC - Stock Observer
US FDA warns of liver injuries, 8 deaths associated with Tavneos | BioWorld
5 Best Pharma Stocks to Invest In Now
US FDA warns of liver injury cases tied to Amgen's rare disease drug - Yahoo News Canada
Amgen's Tavneos Tied to Deaths, Liver Injury, FDA Says (1)
Amgen Inc. $AMGN Shares Purchased by Hofer & Associates. Inc
Amgen Inc. $AMGN is Hofer & Associates. Inc's 5th Largest Position - Daily Political
Mn Services Vermogensbeheer B.V. Acquires 3,327 Shares of Amgen Inc. $AMGN - Daily Political
AMGN: Obesity And Cardiovascular Pipeline Will Support Future Cash Generation
Amgen (AMGN) Stock Up Since Jim Cramer Said "You Could Do a Lot Worse Than Amgen"
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
Vantage Wealth Sells 1,700 Shares of Amgen Inc. $AMGN - Stock Observer
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study
Amgen announces data on Repatha from Phase 3 Vesalius-CV trial | Markets Insider
Amgen Inc. $AMGN Shares Bought by Wealthcare Advisory Partners LLC
Nova R Wealth Inc. Grows Stock Holdings in Amgen Inc. $AMGN - Stock Observer
Amgen's Repatha Data Reinforces Cardiovascular Franchise And Valuation Debate
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure
Industry and academic leaders gather to accelerate new cancer cures
Dakota Wealth Management Acquires 4,581 Shares of Amgen Inc. $AMGN
Amgen News
Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment
US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks
Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles
Market Performance Overview: S&P 500 Rose 1.18%, Earnings Season Q1 2026, Crypto Positive Sentiment
Apple (AAPL) stock overview: Apple Q2 2026 earnings are coming, what to expect on April 30?
Latest news
Show moreHormuz Strait Control: Iran's Post-War Maritime Ambitions and Global Repercussions
Tesla Stock Plummets Over 5% on Disappointing Q1 Delivery and Production Figures
US Non-Farm Payrolls March Report: Robust Rebound Strengthens Dollar, Fuels Fed Policy Debate
EU Assesses Emergency Measures Amid Long-Term Energy Shock Fears from Middle East Conflict
